Switzerland’s biotech hub - a powerful source of innovation
AFSSI Connexions, Convention 2019, July 2nd, Lyon
Michael Altorfer
CEO, Swiss Biotech Association
The Swiss biotech industry is a key asset
Switzerland is one of the best
and most innovative locations
for biotechnology in Europe and
the world
Local companies hold
leading positions throughout many
sectors and thus attract capital and
researchers from all over the world
The basis for this success is a
close-knit network between
research and development, driven
by renowned universities, highly
specialized SMEs and strong
multinational corporations
In addition to being an attractive
place to live for international
specialists, Switzerland also offers a
modern infrastructure, a
beneficial funding environment
and access to a highly-qualified
workforce
swissbiotech.org2
A tight cross-functional network
Cell culture
Engineering
Analytical
Bio-IT
CMO
R&D
Biotech consulting
Non-biotech consulting
Chemicals reagents
Labware
Bio-equipment
Agriculture
Diagnostics
Medtech
Food & industrial
Veterinary
Therapeutics
SBA member
company activities
swissbiotech.org3
Swiss Biotech: Structural changes offer new investment
and partnering opportunities
SBA member
company activities
CMOs take over production sites
CRO share research risk
Clinical trials are outsourced
and even financed by partners
Biotech companies stay independent:
• build their commercial
organizations
• partner with distributors
team up with partners
that have access to
patients
• combine drug and
medical device or
service provider
Investors go it alone, build
virtual project teams rather
than companies
Service providers start
sharing risks and benefit
Some Biotech companies are
fully financed, eliminating the
need for small incremental financing
rounds
Business models not relying
on product development
swissbiotech.org4
Capital investment in Swiss biotech companies
5 Swiss Biotech Day 2019
From 2007 - 2018 Venture Kick invested CHF 3.16 million in 48
Swiss biotech startups. This amount was amplified 159 fold by
grants and VC investments.
6 Swiss Biotech Day 2019
2.0
1.8
1.6
1.4
1.2
1.0
0.8
0.6
0.4
Ma
rke
t co
ve
rag
e
0.6 0.8 1.2 1.4 1.6 1.8 2.0 2.2 2.61.0 2.4
Technology relevance
Bubble size represents the
number of active patents per
country of inventor origin,
reporting year 2016
High impact patents reflect innovation power
USA
France
Australia
Canada
Germany
NetherlandsUK
Denmark
Japan
China
South Korea
Russia
Switzerland
Source: IPI, Swiss Biotech Report 2017 swissbiotech.org7
Major investments in biopharmaceutical production sites
Novartis, 2020
EUR 100 million
Ciba-Geigy,
1996
Roche, 2007
CHF 400 million
MSD (former Werthenstein)
2015, 2008, 2000
MSD (former Werthenstein)
2015, 2008, 2000
UCB Pharma, 2007
CHF 400 million
Ferring, 2001
CHF 30 million
Serono, 1999
EUR 300 million
Lonza, 2020
CHF 290 million
CSL Behring, 2020
CHF 1 billion
Biogen, 2019
CHF 1.5 billion
Cerbios, 2013
SBA, Swiss Biotech Report 2018
Significant and growing export factor
swissbiotech.org9
Swiss Biotech industry in numbers
swissbiotech.org11
Global talent competitiveness
50
55
60
65
70
75
Sco
re
1 2
RankingX
18 16 8 9 24 17 12 40 7 11 10 31 35 5 3 13 25 4 6
Source: Instead, GTCI Report 2017
1 Nation - 1 Biotech Cluster
A world-leading Biotech hub
• Attractive and reliable framework conditions
• Stable political environment
• Strong intellectual property protection
• Renowned universities
• Highly-qualified workforce
• Excellent R&D infrastructure
• Beneficial funding environment
• Superb quality of life
swissbiotech.org13
Swiss Biotech Association
The central resource for the Swiss biotech industry
3M • Abologix • AC Bioscience • AC Immune • Activen • ADC Therapeutics • Addex Therapeutics • Adolf Kuhner • Agidens • Alphastrat • AlveoliX • Amal Therapeutics • Anaveon • Anergis • Anjarium Biosciences •
Asceneuron • Assystem Care • Aurealis Pharma • Axon Lab • B3C Group • Baccinex • Bachem • Baliopharm • Basilea Pharmaceutica • BC Platforms • Becton Dickinson • Bench • Bideco • Bio Innovations • BioConcept
• Bioengineering • Biogen • BioLingus • Biomapas • Biopole • Bio-Rad • Biosynth • Bio- Technopark Schlieren-Zurich • BioVersys • blsc • Bucher Biotec • Buchi • BUHLMANN • Cabinet Prive de Conseils • Calypso
Biotech • Canlion • Carbogen Amcis • CarthaGenetics • C-CIT Sensors • CDR-Life • CEBIS International • Celerion • Cell Medica • Cellestia Biotech • Cerbios-Pharma • certus molecular diagnostics • Chemgineering
Technology • Cilatus Biopharma Consulting • CimArk • CIS Pharma • Clinipace • Consultants in Science • Coulter & Partners • CRB • Creoptix • CSL Behring • CTC Clinical Trial Consulting • Culture Collection of
Switzerland • Curatis • Debiopharm International • DXC RT • EffRx Pharmaceuticals • Elanix Biotechnologies • Elthera • Eurofins Medical Device Testing • EVA • Evitria • ExcellGene • ExpertInova • Finox Biotech •
Future Health Pharma • Gain Therapeutics • GBiotech • GE Healthcare • Geistlich Pharma • Gene Signal • Genedata • GeNeuro • Genkyotex • Glenmark Pharmaceuticals • GMT Fine Chemicals • Healthcare Impact
Foundation • Hemex • Heptares Therapeutics • HGF • Homburger • Humabs BioMed • IBR • ICON Clinical Research • Idorsia Pharmaceuticals • IE Life Science Engineering • Incyte Biosciences International •
Inflamalps • Infors • InnoMedica • Inofea • Inositec • InSphero • Integra Biosciences • InterAx Biotech • Janssen-Cilag • Jenal & Partners Biosafety Consulting • Jung & Partners • KPMG • Labatec Pharma • Laves-
Arzneimittel • LeadXpro • LimmaTech Biologics • Lipidon • Lonza • Loroch • LubioScience • Lunaphore Technologies • LYO-X • Malcisbo • Marsa Corporate Finance • Maxia Strategies • MD Biosciences • Med
Discovery • Mediatum • Memo Therapeutics • Merck & Cie • MetrioPharm • Micro-Sphere • Microsynth • Molecular Partners • Morgan Sindall • Mymetics • NBE-Therapeutics • NDA • Neurimmune • Novartis Pharma •
NovImmune • Numab • ObsEva • Oculis • OLS • Omya • Onelife • P & G MedChem • Pall • PAREXEL • Phargentis • Philip Morris International • Philochem • Phoenixus Pharmaceuticals • PIQUR • PolyGene •
Polyneuron • Polyphor • Preclin Biosystems • PreComb Therapeutics • Promega • ProteoMediX • PSI CRO • Quotient Suisse • Recordati • Redbiotec • RegenLab • regulanet • ReseaChem • Roche Glycart • SAKK •
Santhera • Sartorius • Schmidt Versicherungs Treuhand • Seagen International • Securecell • Selexis • Servier • SFL Pharma • SGS M-Scan • Shimadzu • SimplicityBio • Socorex • SOPHiA GENETICS • SpacePharma
• Dr. Rudolf K.Sprungli • Strekin • SunRegen Healthcare • Swiss Institute for Regenerative Medicine • Swissfillon • Switzerland Global Enterprise • SynDermix • Syngenta • Synlab • Synple Chem • T3 Pharma •
Talentmark • Target BioScience • tepthera • the RSA Group • Therachon • Thermo Fisher Life Technologies • Thermo Fisher Scientific Prionics • Tigermed • Tillotts Pharma • tiventa • TJM Conseils • Tolerys •
TOLREMO therapeutics • Toolpoint for Lab Science • Topadur • Triplan Ingenieur • UCB • Unitectra • ValuationLab • Vaxxilon • Venture Valuation • Versameb • Versantis • Virometix • Voisin Consulting Life Sciences •
MSD Werthenstein BioPharma • Wyss Zurich
swissbiotech.org15
Members of the Swiss Biotech Association (255)
Our mission
swissbiotech.org16
Developing favorable and
competitive framework
conditions
Attracting talent, know-how and
financial resources to drive
innovation and growth
Technology transfer
Academia – Industry
collaborationsTaxation
Seed / venture
capital
Clinical
developments
Industry – Hospital
collaborations
Swiss Biotech Association
Improving framework conditions
swissbiotech.org17
Promotion support
Biotech directory,
jobs, clinical pipeline
SBA Academy
Seminars
Workshops
Discounted business
offerings (e.g.
pension fund)
Co-promotions
Discounted access
Speaker
opportunities
Swiss Biotech Association
Business solutions
swissbiotech.org18
swissbiotech.org19
Our mission
Promoting the
accomplishments of the
Swiss biotech industry
Fostering networking through
strategic, national and
international partnerships
Developing favorable and
competitive framework
conditions
Attracting talent, know-how and
financial resources to drive
innovation and growth
The Swiss Biotech DirectoryFinding the right partner – Switzerland's most comprehensive database
www.swissbiotech.org/companies/
swissbiotech.org20
The Swiss Biotech Association has launched Swiss Biotech Success Stories to
celebrate those who have made significant contributions to the industry
Dedicated to scientists, pioneers, entrepreneurs, innovators and supporters who led
the way, opened the horizon and prepared the ground for lasting achievements
Swiss Biotech Success Stories accentuate past industry highlights and act as
motivator for future achievements
Celebrating and honoring major achievements
General Assembly,
May 7, 2019
swissbiotech.org23
Award winner 2019
Launched the Swiss Biotech Success Stories Award
The first awards went to:
• Biogen
• Okairos
• Roche Glycart
• Selexis
• Vifor Fresenius Renal Medical Care Pharma
swissbiotech.org34
National biotech convention: Swiss Biotech Day in Basel
> 850 participants (plus 30%)
42 exhibitors (plus 55%)
38% participants from abroad (plus 5%)
1st year of success story award
906 organizations in
Swiss Biotech Directory (plus 35%)
47 new members of the
Swiss Biotech Association (plus 25%)
> 30 co-promotion partner
(plus 200%)
2019 Swiss Biotech
Report
Top Related